NCT04172987View on ClinicalTrials.gov

A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

February 9, 2021

Study Completion Date

February 9, 2021

Conditions

Healthy

Interventions

DRUG

Tirzepatide

Administered SC

DRUG

EE/NGM

Combination oral contraceptive administered orally

Trial Locations (1)

75247

Covance Dallas, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT04172987 - A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants | Biotech Hunter | Biotech Hunter